On July 31, Corteva, Inc. declined 10.51% in regular trading, trading at approximately $79.86/share, with turnover of $3.6 billion. The sharp selloff followed the company's Q2 earnings release.

Corteva reported Q2 adjusted earnings of $2.30 per diluted share, beating the FactSet consensus estimate of $2.22-$2.24 and up from $2.20 a year earlier. However, revenue fell to $6.38 billion from $6.46 billion year-over-year, significantly missing the analyst estimate of approximately $6.58-$6.6 billion. While the company raised its full-year operating EPS guidance to a range of $3.60-$3.80, up from a prior forecast of $3.45-$3.70, the revenue shortfall weighed heavily on sentiment. Earlier this year, Corteva had flagged persistent pricing headwinds in its crop protection segment, with low-single-digit price declines expected for the year. Multiple analysts had already downgraded the stock to neutral prior to the earnings release.

Within the Fertilizers & Agricultural Chemicals sector, weakness was broad-based. Among peers, FMC Corp fell 7.35%, Mosaic fell 2.06%, Scotts Miracle-Gro fell 1.48%, Nutrien Ltd. fell 1.4%, and CF Industries fell 0.92%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)